BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis, and evaluation of diarylpyridines and diarylanilines as potent non-nucleoside HIV-1 reverse transcriptase inhibitors. 2010

Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Beijing Institute of Pharmacology & Toxicology, 27 Tai-Ping Road, Beijing 100850, China.

On the basis of the structures and activities of our previously identified non-nucleoside reverse transcriptase inhibitors (NNRTIs), we designed and synthesized two sets of derivatives, diarylpyridines (A) and diarylanilines (B), and tested their anti-HIV-1 activity against infection by HIV-1 NL4-3 and IIIB in TZM-bl and MT-2 cells, respectively. The results showed that most compounds exhibited potent anti-HIV-1 activity with low nanomolar EC50 values, and some of them, such as 13m, 14c, and 14e, displayed high potency with subnanomolar EC50 values, which were more potent than etravirine (TMC125, 1) in the same assays. Notably, these compounds were also highly effective against infection by multi-RTI-resistant strains, suggesting a high potential to further develop these compounds as a novel class of NNRTIs with improved antiviral efficacy and resistance profile.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D013058 Mass Spectrometry An analytical method used in determining the identity of a chemical based on its mass using mass analyzers/mass spectrometers. Mass Spectroscopy,Spectrometry, Mass,Spectroscopy, Mass,Spectrum Analysis, Mass,Analysis, Mass Spectrum,Mass Spectrum Analysis,Analyses, Mass Spectrum,Mass Spectrum Analyses,Spectrum Analyses, Mass
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Optimization of 2,4-diarylanilines as non-nucleoside HIV-1 reverse transcriptase inhibitors.
April 2012, Bioorganic & medicinal chemistry letters,
Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Synthesis and biological evaluation of (±)-benzhydrol derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
August 2011, Bioorganic & medicinal chemistry,
Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Rational design of potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
December 2012, Journal of medicinal chemistry,
Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Design, synthesis, and preclinical evaluations of novel 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) drug candidates.
August 2012, Journal of medicinal chemistry,
Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
[Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].
November 2009, Yao xue xue bao = Acta pharmaceutica Sinica,
Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
February 2019, ACS medicinal chemistry letters,
Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis and biological evaluation of novel quinoxalinylethylpyridylthioureas as potent antiviral agents.
March 2000, Antiviral chemistry & chemotherapy,
Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Pharmacophore-fusing design of pyrimidine sulfonylacetanilides as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase.
March 2020, Bioorganic chemistry,
Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
June 2014, Bioorganic & medicinal chemistry,
Xingtao Tian, and Bingjie Qin, and Zhiyuan Wu, and Xiaofeng Wang, and Hong Lu, and Susan L Morris-Natschke, and Chin Ho Chen, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Design, synthesis, and biological evaluations of novel quinolones as HIV-1 non-nucleoside reverse transcriptase inhibitors.
August 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!